Contrast-enhanced sonography with abdominal virtual sonography in monitoring radiofrequency ablation of hepatocellular carcinoma

Journal of Clinical Ultrasound

Volumn 38, Issue 3, 2010, Pages 138-144

  Kisaka, Yoshiyasu ^a   Hirooka, Masashi ^a   Koizumi, Yohei ^a   Abe, Masanori ^a   Matsuura, Bunzo ^a   Hiasa, Yoichi ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Contrast enhanced ultrasonography; Hepatocellular carcinoma (hcc); Liver; Radio frequency ablation; Therapeutic response; Virtual ultrasonography

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; POLYSACCHARIDE; SHU 508;

AGED; ARTICLE; CATHETER ABLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; ECHOGRAPHY; FEMALE; HUMAN; IMAGE ENHANCEMENT; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METHODOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; LIVER; LIVER NEOPLASMS; MALE; POLYSACCHARIDES; PROSPECTIVE STUDIES; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 77949439754     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.20654     Document Type: Article

References (29)

1. El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745.
2. Taylor Robinson SD, Foster GR, Arora S, et al. Increase in primary liver cancer in the UK, 1989-94. Lancet 1997;350:1142.
3. Okuda K, Okuda H. Primary liver carcinoma. In: McIntyre N, Benhamou T, Bircher J, editors. Oxford text book of clinical hepatology. Volume 2. Oxford, England: Oxford University Press; 1991, p 1019.
4. Bruix J, Sherman M, Llovert JM, et al. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusion of the Barcelona-2000 EASL Conference European Association for the Study of the Liver. J Hepatol 2001;35:421.
5. Ryder S D. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003;52:iii1.
6. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907.
7. Balsells J, Charco R, Lazaro JL, et al. Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 1996;83:758.
8. Akamatsu K, Miyauchi S, Itoh Y, et al. Development and evaluation of a needle for percutaneous ethanol injection therapy. Radiology 1993;186:284.
9. Shiina S, Tagawa K, Unuma T, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer 1991;68: 1524.
10. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: longterm results of percutaneous ethanol injection. Radiology 1995;197:101.
11. Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994;74:817.
12. Murakami R, Yoshimatsu S, Yamashita Y, et al. Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation. Am J Roentgenol 1995;164:1159.
13. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumours by an expandable RF needle electrode. Am J Roentgenol 1998;170:1015.
14. Goldberg SN, Gazelle GS, Solbiati L, et al. Ablation of liver tumours using percutaneous RF therapy. Am J Roentgenol 1998;170:1023.
15. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103:1201.
16. Horiike N, Iuchi H, Ninomiya T. Influencing factors for recurrence of hepatocellular carcinoma treated with radiofrequency ablation. Oncol Rep 2002;9:1059.
17. Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997;202:195.
18. Livraghi T, Goldberg SN, Monti F, et al. Salineenhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology 1997;202: 582.
19. Berrington de Gonza'lez A, Darby S. Risk of from diagnostic X-rays; estimates for the UK and 14 other countries. Lancet 2004;363:345.
20. Shimizu M, Iijima H, Horibe T, et al. Usefulness of contrast enhanced ultrasonography with a new contrast mode, agent detection imaging, in evaluating therapeutic response in hepatocellular carcinoma treated with radio-frequency ablation therapy. Hepatol Res 2004;29:235.
21. Hirooka M, Iuchi H, Kurose K, et al. Abdominal virtual ultrasonographic images reconstructed by multi-detector row helical computed tomography. Eur J Radiol 2005;53:312.
22. Hirooka M, Iuchi H, Kumagi T, et al. Radiofrequency ablation using virtual ultrasonography of hepatocellular carcinoma visualized on CT not on conventional ultrasonography. Am J Roentgenol 2006;186:S255.
23. Kisaka Y, Hirooka M, Kumagi T, et al. Usefulness of contrast enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation. Liver Int 2006;26:1241.
24. Koda M, Ueki M, Maeda Y, et al. Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. Am J Roentgenol 2004;183:583.
25. Kim YS, Rhim H, Cho OK, et al. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma; analysis of the pattern and risk factor. Eur J Radiol 2006;59: 432.
26. Choi BI, Kim HC, Han JK, et al. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma. CT and pathologic findings. Radiology 1992; 182:709.
27. Gazelle GS, Goldberg SN, Solbiati L, et al. Tumour ablation with radio-frequency energy. Radiology 2000;217:633.
28. Yamamoto K, Shiraki K, Nakanishi S, et al. 1.5 Harmonic imaging sonography with microbubble contrast agent improve characterization of hepatocellular carcinoma. World J Gastroenterol 2005;11: 5607.
29. Dutcher JP, Haney PJ, Whitley NO, et al. Ethiodized oil emulsion 13 in computed tomography of hepatoma. J Clin Oncol 1984;2:118.